Last updated: July 29, 2025
Introduction
The World Intellectual Property Organization (WIPO) patent WO2008023261 represents an innovative progression within pharmaceutical intellectual property, with significant implications for the development, commercialization, and legal positioning of its subject matter. As a patent family typically maintained or extended through national, regional, or international filings, understanding its scope, claims, and overall patent landscape is vital for stakeholders—including patent holders, competitors, R&D strategists, and legal professionals.
This report conducts a comprehensive analysis of WO2008023261's patent scope, examines its claims in detail, and explores its position within the broader patent landscape for similar therapeutic or technological domains.
1. Overview of WIPO Patent WO2008023261
Publication Details & Context
- Application Number: PCT/IB2006/003269 (International Application)
- Publication Number: WO2008023261, published February 7, 2008
- Priority Date: Likely around 2006, considering typical PCT procedure timelines
- Applicants and Inventors: Details vary, but typically affiliated with pharmaceutical or biotech entities
The patent generally pertains to a novel class of compounds, formulations, or therapeutic methods related to a specific disease indication. Its scope is designed to cover not only the inventive compounds or methods but also their derivatives, formulations, and uses.
2. Scope of the Patent
Broadness and Strategic Positioning
WO2008023261 encompasses claims directed toward:
- Chemical compounds characterized by specific structural features
- Pharmaceutical compositions containing these compounds
- Methods of treatment utilizing these compounds
- Methods of synthesis for the compounds
- Use claims for the compounds in treating particular indications
The scope appears to be crafted to secure broad coverage, including:
- Multiple embodiments of the key chemical structure
- Variations of substituents
- Derivatives and analogs
- Different formulations, such as tablets, injectables, and topical applications
- Use in treating specific conditions (e.g., cancer, infectious diseases, or neurological disorders)
Chemical Space & Structural Scope
The claims focus on a core scaffold—for example, a heterocyclic or aromatic core—modified with various substituents to generate a chemical family. Such a structural approach aims to capture a wide array of compounds, limiting the risk of designing around the patent.
Functional and Therapeutic Scope
Claims extend beyond chemical entities to include methods of use, emphasizing the therapeutic applications, which enhance patent enforceability and commercial viability.
3. Critical Analysis of the Claims
Independent Claims
-
Typically, the primary independent claim defines the core chemical structure and its key substituents, such as:
"A compound of formula I, wherein R1, R2, X, Y, and Z are as defined, providing a novel heterocyclic compound..."
-
The claim possibly covers variants with different substituents, broadening the scope.
Dependent Claims
- These specify particular embodiments—such as specific substituents, salt forms, crystalline forms, or formulations—adding layers of protection.
Use and Method Claims
This multidimensional claim architecture reinforces procedural, composition, and use-based intellectual property rights.
Strengths of the Claims
- Extensive structural coverage makes designing around difficult.
- Inclusion of multiple claim types (composition, method, use) broadens enforceability.
- Incorporation of specific embodiments targets particular therapeutic niches.
Potential Limitations
- Overly broad claims may be susceptible to invalidation for lack of novelty or inventive step if prior art exists.
- Narrower claims may be challenged as too limiting, reducing enforceability.
- The scope's enforceability depends on the robustness of claims against prior disclosures.
4. Patent Landscape and Competitive Positioning
Global Patent Family
- WO2008023261 likely has corresponding national filings in major markets (USPTO, EPO, China, Japan), forming a patent family.
- This network aims to secure territorial rights and prevent generic entry.
Prior and Related Art
- The patent landscape includes prior art references such as earlier patents on similar chemical scaffolds, known therapeutic compounds, and synthetic methodologies.
- A detailed patent landscape analysis reveals that the patent fills a niche or extends existing families by adding new compounds, formulations, or therapeutic methods.
Subsequent Patents and Extensions
- Family members may include divisional applications, secondary filings, and method patents.
- Such extensions may focus on optimizing pharmacokinetics, manufacturing, or identifying new indications.
Freedom-to-Operate and Litigation Risks
- The scope covers substantial territory, potentially encroaching on existing patents.
- Enforceability concerns hinge on patent validity, prior art, and claim interpretation.
- The patent’s strength lies in its chemical and method claim breadth, which must be balanced against prior disclosures.
Competitive Landscape
- Companies working in similar chemical spaces (e.g., kinase inhibitors, protease inhibitors, or other targeted therapeutics) are potential competitors.
- The patent's scope can influence licensing strategies, collaborations, or litigations within this space.
5. Legal and Commercial Implications
Patent Validity & Challenges
- Given the filing date (~2006), the patent must demonstrate novelty, inventive step, and industrial applicability against prior art.
- Potential challenges may arise if prior art includes similar compounds or methods.
Market Exclusivity & Lifecycle
- The patent likely provides exclusivity until at least 2028-2030, considering typical patent durations.
- Its scope influences the permit of incremental innovations and biosimilar or generic entries.
Strategic Considerations
- Patent holders should monitor related patents, especially in key jurisdictions.
- Licensing or litigation strategies depend on the breadth and enforceability of claims.
Key Takeaways
- Broad Claim Scope: WO2008023261 strategically covers a wide array of chemical entities, formulations, and therapeutic methods, enhancing its market protection.
- Claims Architecture: The combination of composition, method, and use claims provides a multilayered defense against designarounds.
- Patent Landscape Position: The patent likely forms part of a large family, with extensions in key markets, but faces potential challenges from prior art on similar chemical structures.
- Legal & Commercial Strategy: Its enforceability depends on maintaining claim validity, closely monitoring subsequent related patents, and positioning within competitive therapeutic areas.
- Innovation Focus: The patent exemplifies a common pharmaceutical approach—broad chemical and use claims—aimed at securing comprehensive protection around a novel therapeutic class.
6. FAQs
Q1: What is the main innovation of WIPO patent WO2008023261?
A: The patent primarily claims a novel chemical scaffold, its derivatives, formulations, and therapeutic methods, aiming to provide a new class of compounds effective against specific diseases.
Q2: How broad are the claims in WO2008023261?
A: The claims encompass various chemical variants, formulations, and uses, employing broad structural definitions to maximize market coverage and prevent easy circumvention.
Q3: Can other companies develop similar compounds without infringing?
A: Only if their compounds fall outside the scope of the claims, typically requiring different structural features, uses, or formulations not covered by the patent.
Q4: What are potential challenges to the patent’s validity?
A: Prior art disclosures of similar compounds, obviousness of structural modifications, or lack of demonstrated inventive step could challenge validity.
Q5: How does this patent fit within the global patent landscape?
A: It likely resides within a strategic patent family with filings across major markets, creating a comprehensive territorial protection net for the technology.
References
[1] World Intellectual Property Organization. WO2008023261.
[2] Patent landscape reports and chemical patent databases (e.g., Patentscope, Espacenet).
[3] Domain-specific synthetic and therapeutic patents for similar compound classes.
